Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of treatment modality on in-hospital outcome in patients with subarachnoid hemorrhage: a nationwide study in Japan (J-ASPECT Study).
Kurogi R, Kada A, Nishimura K, Kamitani S, Nishimura A, Sayama T, Nakagawara J, Toyoda K, Ogasawara K, Ono J, Shiokawa Y, Aruga T, Miyachi S, Nagata I, Matsuda S, Yoshimura S, Okuchi K, Suzuki A, Nakamura F, Onozuka D, Hagihara A, Iihara K; J-ASPECT Study Collaborators. Kurogi R, et al. Among authors: nakagawara j. J Neurosurg. 2018 May;128(5):1318-1326. doi: 10.3171/2016.12.JNS161039. Epub 2017 May 26. J Neurosurg. 2018. PMID: 28548595
Nationwide survey of antihypertensive treatment for acute intracerebral hemorrhage in Japan.
Koga M, Toyoda K, Naganuma M, Kario K, Nakagawara J, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Yamagami H, Kimura K, Okada Y, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Koga M, et al. Among authors: nakagawara j. Hypertens Res. 2009 Sep;32(9):759-64. doi: 10.1038/hr.2009.93. Epub 2009 Jun 26. Hypertens Res. 2009. PMID: 19557007
Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.
Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. Toyoda K, et al. Among authors: nakagawara j. Stroke. 2009 Nov;40(11):3591-5. doi: 10.1161/STROKEAHA.109.562991. Epub 2009 Sep 17. Stroke. 2009. PMID: 19762694
[Effects of statin use on intracranial hemorrhage and clinical outcome after intravenous rt-PA for acute ischemic stroke: SAMURAI rt-PA registry].
Makihara N, Okada Y, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Hasegawa Y, Kario K, Okuda S, Naganuma M, Toyoda K. Makihara N, et al. Among authors: nakagawara j. Rinsho Shinkeigaku. 2010 Apr;50(4):225-31. doi: 10.5692/clinicalneurol.50.225. Rinsho Shinkeigaku. 2010. PMID: 20411804 Japanese.
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K. Naganuma M, et al. Among authors: nakagawara j. Cerebrovasc Dis. 2011;31(2):123-9. doi: 10.1159/000321516. Epub 2010 Nov 17. Cerebrovasc Dis. 2011. PMID: 21088392 Free article.
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
Koga M, Kimura K, Shibazaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Nezu T, Maeda K, Minematsu K, Toyoda K. Koga M, et al. Among authors: nakagawara j. J Neurol Sci. 2011 Jul 15;306(1-2):49-53. doi: 10.1016/j.jns.2011.03.046. Epub 2011 Apr 14. J Neurol Sci. 2011. PMID: 21492878
Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K. Nezu T, et al. Among authors: nakagawara j. Stroke. 2011 Aug;42(8):2196-200. doi: 10.1161/STROKEAHA.111.614404. Epub 2011 Jun 30. Stroke. 2011. PMID: 21719764
Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation.
Maeda K, Koga M, Okada Y, Kimura K, Yamagami H, Okuda S, Hasegawa Y, Shiokawa Y, Furui E, Nakagawara J, Kario K, Nezu T, Minematsu K, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Maeda K, et al. Among authors: nakagawara j. J Neurol Sci. 2012 Jan 15;312(1-2):82-5. doi: 10.1016/j.jns.2011.08.017. Epub 2011 Aug 27. J Neurol Sci. 2012. PMID: 21875722
Low-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry.
Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Endo K, Miyagi T, Osaki M, Minematsu K, Toyoda K. Koga M, et al. Among authors: nakagawara j. Stroke. 2012 Jan;43(1):253-5. doi: 10.1161/STROKEAHA.111.631176. Epub 2011 Sep 29. Stroke. 2012. PMID: 21960585
178 results